17/06/2026
Join GlomCon and ISN this Sunday: Do We Need Kidney Biopsy in Alport Spectrum Disorders?
Danica Ljubanović and Helen Liapis
ID: 875 5077 1266
Passcode: 202122
sign up 👉 https://ow.ly/qw7p50SfqkM
17/06/2026
Join us today at 4:00 pm CEST for an in-depth X Space discussion on "Ebola & the Kidneys: What We Know So Far." Our expert panel—Yannick Nlandu Mayamba, Robert Kalyesubula, and Henry Kyobe Bosa—will examine current research, knowledge gaps, and preparedness efforts related to kidney involvement in Ebola virus disease.
Access the X Space here: https://twitter.com/i/spaces/1PKqrrWpoOeGb
Ahead of the event, we encourage you to review our Ebola & Kidney Health tweetorial, by Priyadarshini John and Sandhya Suresh: https://x.com/ISNkidneycare/status/2067149702316052524?s=20
You can also assess your understanding with our Ebola quiz, by ISN Social Media Committee members: https://theisn.outgrow.us/ebola_kidney
We welcome your participation as we advance critical conversations on kidney health in the context of emerging infectious diseases.
17/06/2026
📣 Available on ISN Academy (with CME credits): Empowering Non-Physician Healthcare Workers: Early Detection and Management of Kidney Disease.
This curriculum is designed to strengthen the ability of non-physician healthcare professionals to recognize early signs of CKD and support timely, effective care.
Explore the program and share with colleagues beyond kidney care:
https://bit.ly/4tC8Vsy
As an ISN member, you can enjoy over 8,500 hours of educational content and 12 annual scientific publications that keep you ahead of the curve in nephrology advancements. Join/renew your ISN membership for the rest of 2026 at 50% off, use code 50ISN26 ➡️ https://bit.ly/4fUZ0e1
16/06/2026
Access the latest edition of the ISN Journals eDigest.
This collection of Kidney International® articles focuses on improving risk prediction and enabling earlier prevention to strengthen the evidence base for kidney care.
The Kidney International Reports® collection highlights studies on telehealth, artificial intelligence, and community health worker-led interventions aimed at improving access and outcomes across diverse patient populations.
🔗 https://bit.ly/449MUGT
– Advancing kidney health worldwide. Together.
15/06/2026
Over the past 10 years, Kidney International Reports® has helped expand access to kidney research worldwide through its commitment to open access and global representation by supporting submissions from every region, the journal has played a key role in making new evidence more accessible to clinicians and researchers.
In 2026 Kidney Studio interview, past Editor-in-Chief Jai Radhakrishnan reflects on the journal’s evolution and shares his vision for making emerging science even more accessible in the years ahead.
Read more to watch an interview with past Editor-in-Chief Jai Radhakrishnan reflecting on the journal’s journey and learn how to apply for the opportunity to become KIR’s next Editor-in-Chief ➡️ https://bit.ly/4fGniZj
15/06/2026
𝗧𝗢𝗗𝗔𝗬: ISN-KDIGO webinar: "Targeting B cells in glomerular diseases."
🗣️ Jürgen Floege, Brad Rovin
👤 Isabelle Ayoub
🗓️ June 15
🕑 4 pm CEST
🔗 Free registration: https://bit.ly/3PzyIn9
12/06/2026
ISN was delighted to attend and endorse the Korean Society of Nephrology (KSN) Meeting and to host the KSN–ISN Joint Symposium, Innovations and Advances in Kidney Disease Management.
The session brought together leading experts to discuss global kidney health policy, telemedicine, translational research, and emerging approaches to chronic kidney disease care. We thank Professors Marcello Tonelli, Masaomi Nangaku, Soo Wan Kim, and Kook-Hwan Oh for sharing their valuable insights and expertise.
We also thank KSN for their warm hospitality and for delivering an outstanding scientific meeting. ISN commends KSN's Kidney Health Plan 2033 (KHP 2033), a forward-looking initiative that reflects a strong commitment to advancing kidney health and improving care for people living with kidney disease.
대한신장학회
12/06/2026
📖 This weekend don't miss our Kidney International Reports : Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE.
➡ https://bit.ly/4dL5MQR
Grow professionally with the ISN. Access high-impact scientific and clinical research through our journals. Join/renew your ISN membership ➡️ https://bit.ly/4vsDrXJ
– Advancing kidney health worldwide. Together.